Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The disease-causing gene that is being targeted for replacement or supplementation via adeno-associated viral (AAV) vector delivery. The specific gene and its function depend on the disease being treated. AAV vectors are engineered to deliver a functional copy of the gene to target cells, compensating for the defective or missing endogenous gene. The cell-surface molecules (receptors) that mediate uptake of specific AAV serotypes are also considered targets to allow efficient gene delivery. Examples include fibroblast/hepatocyte growth factor receptor, integrins αVβ5/α5β1, epidermal growth factor receptor, platelet-derived growth factor receptor and AAVR.
Gene replacement or supplementation via AAV vector delivery
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Disease-causing gene.